Author: News Room

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paysafe To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Paysafe between March 4, 2025 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Paysafe Limited (“Paysafe” or the…

Read More

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beyond Meat To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Beyond Meat between February 27, 2025 and November 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beyond Meat, Inc. (“Beyond Meat”…

Read More

High Resolution Artwork HERE LOS ANGELES, Feb. 26, 2026 (GLOBE NEWSWIRE) — WHAT:“Gloria Trevi: Live from BMO Stadium” Stadium will be available for an advance purchase price of $24.99 and a day-of-the-event PPV price of $29.99. (Excluding California.)From her chart-topping anthems to her most powerful ballads, Gloria brings you the passion, drama, and unstoppable spirit that have made her a fan favorite. Gloria will bring several surprise guests on stage, as well as exclusive behind-the-scenes footage before and after the show. This special event will capture Trevi’s only U.S. concert in 2026, a celebration of life: a sold-out night at…

Read More

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options If you suffered significant losses in Hub Group stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG).…

Read More

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Helen of Troy To Contact Him Directly To Discuss Their Options If you suffered significant losses in Helen of Troy stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Helen of Troy Limited (“Helen of Troy” or…

Read More

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BlackRock TCP To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BlackRock TCP between November 6, 2024 and January 23, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BlackRock TCP Capital Corp. (“BlackRock…

Read More

BALTIMORE, Feb. 26, 2026 (GLOBE NEWSWIRE) — Today, the American Urological Association (AUA), in partnership with the Society of Urologic Oncology (SUO), released the 2026 amendment to the Early Detection of Prostate Cancer Guideline. This Guideline is intended to provide a framework to facilitate clinical decision-making in the implementation of prostate cancer screening and follow-up. “This amendment reflects our continued commitment to ensuring that patients and clinicians have access to the most current, evidence‑based recommendations for early detection of prostate cancer,” said Guideline Amendment Chair, Dr. Daniel Lin. “As the science evolves, so must our guidance. These updates incorporate the…

Read More

NEW YORK, NY, Feb. 26, 2026 (GLOBE NEWSWIRE) — NEW YORK, NY – Budgyt, a business budgeting software platform for mid-market and nonprofit organizations, is ideally positioned as a structured alternative to spreadsheet-based budgeting in multi-department environments. Designed for organizations with 20+ employees, four or more departments, distributed budget contributors, and formal board oversight, Budgyt focuses on structural financial control without enterprise-level complexity. Finance teams often outgrow Excel long before they replace it. At scale, spreadsheets become fragile. _____ When 8,000+ Formulas Become Governance Risk In multi-department organizations, budgeting models frequently require: 8,000+ roll-up formulas for 10 departmentsExponential formula growth…

Read More

Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) — The “Contraceptive Drug Eluting Devices Market – Global Forecast 2026-2032” report has been added to ResearchAndMarkets.com’s offering. The global contraceptive drug eluting devices market is experiencing robust expansion, driven by advancements in materials science, increasing emphasis on patient-centric care, and evolving policy landscapes. Contraceptive drug eluting devices are reshaping the reproductive care landscape by combining controlled release technology with real-world patient needs. These combination products strive to bolster adherence, lower user burden, and ensure reliable outcomes for both patients and providers in a dynamic healthcare environment. Growing awareness of reproductive autonomy, ongoing regulatory…

Read More

ROAD TOWN, British Virgin Islands, Feb. 26, 2026 (GLOBE NEWSWIRE) — Aura Minerals Inc. (NASDAQ: AUGO) (B3: AURA33) (“Aura” or the “Company”) announces that it has filed its audited consolidated financial statements and earnings release (together, “Financial and Operational Results”) for the period ended December 30, 2025. The full version of the Financial and Operational Results can be viewed on the Company’s website at www.auraminerals.com, on SEDAR+ at www.sedarplus.ca. or on SEC www.sec.com. Rodrigo Barbora, Aura’s President, and CEO commented: “We are delighted to report that higher production, higher metal prices and stable costs have once again driven Aura to…

Read More